| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 22 |
| 1 | ADALIMUMAB | 11 |
| 2 | PACLITAXEL | 11 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 11 |
| 4 | ERGOCALCIFEROL | 10 |
| 5 | CAPECITABINE | 9 |
| 6 | CARBOPLATIN | 9 |
| 7 | LEVOTHYROXINE SODIUM | 9 |
| 8 | LISINOPRIL | 8 |
| 9 | CYCLOPHOSPHAMIDE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRETOMANID | 1 | 0.0013 |
| 1 | RESMETIROM | 3 | 0.0013 |
| 2 | NITISINONE | 1 | 0.0010 |
| 3 | NIRAPARIB | 22 | 0.0010 |
| 4 | NIMODIPINE | 1 | 0.0009 |
| 5 | COLESTIPOL HYDROCHLORIDE | 2 | 0.0008 |
| 6 | GLYCEROL PHENYLBUTYRATE | 1 | 0.0007 |
| 7 | BEDAQUILINE FUMARATE | 1 | 0.0007 |
| 8 | TAMOXIFEN CITRATE | 4 | 0.0007 |
| 9 | BELZUTIFAN | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 13 |
| 1 | Microtubule Inhibitor [EPC] | 11 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 11 |
| 3 | Platinum-based Drug [EPC] | 10 |
| 4 | Vitamin C [EPC] | 8 |
| 5 | Alkylating Drug [EPC] | 7 |
| 6 | Corticosteroid [EPC] | 7 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 7 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Receptor beta Agonist [EPC] | 3 | 0.0013 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Somatostatin Analog [EPC] | 3 | 0.0004 |
| 3 | Cannabinoid [EPC] | 1 | 0.0001 |
| 4 | Phenothiazine [EPC] | 3 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 4 | 0.0001 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |
| 8 | Anticholinergic [EPC] | 1 | 0.0001 |
| 9 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |